The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice
Open accessAbstract
The National Institute on Aging's Interventions Testing Program was established to evaluate agents that are purported to increase lifespan and delay the appearance of age‐related disease in genetically heterogeneous mice. Up to five compounds are added to the study each year and each compound is tested at three test sites (The Jackson Laboratory, University of Michigan, and University of Texas Health Science Center at San Antonio). Mice in the first cohort were exposed to one of four agents: aspirin, nitroflurbiprofen, 4‐OH‐α‐phenyl‐N‐tert‐butyl nitrone, or nordihydroguaiaretic acid (NDGA). Sample size was sufficient to detect a 10% difference in lifespan in either sex, with 80% power, using data from two of the three sites. Pooling data from all three sites, a log‐rank test showed that both NDGA ( p = 0.0006) and aspirin ( p = 0.01) led to increased lifespan of male mice. Comparison of the proportion of live mice at the age of 90% mortality was used as a surrogate for measurement of maximum lifespan; neither NDGA ( p = 0.12) nor aspirin ( p = 0.16) had a significant effect in this test. Measures of blood levels of NDGA or aspirin and its salicylic acid metabolite suggest that the observed lack of effects of NDGA or aspirin on lifespan in females could be related to gender differences in drug disposition or metabolism. Further studies are warranted to find whether NDGA or aspirin, over a range of doses, might prove to postpone death and various age‐related outcomes reproducibly in mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, long-term treatment with the NSAID aspirin prolonged lifespan in genetically heterogeneous wt mice56.”
From Chronic inflammation induces telomere dysfunction and accelerates ageing in mice (2014) · cites this paper as [56]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the long-term administration of anti-inflammatory agents such as aspirin may increase longevity in mice and healthy aging in humans (Rothwell et al., 2011; Strong et al., 2008).”
From The Hallmarks of Aging (2013) · cites this paper as Strong et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The National Institute on Aging Interventions Testing Program (ITP) evaluates agents that may delay ageing and increase lifespan in genetically heterogeneous mice15–17.”
From Rapamycin fed late in life extends lifespan in genetically heterogeneous mice (2009) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“Female mice given 2500 ppm had lower blood levels of NDGA compared with males, suggesting that the sex effect might reflect sex‐specific differences in drug metabolism or excretion (Strong et al., 2008).”
From Longer Lifespan in Male Mice Treated With a Weakly Estrogenic Agonist, an Antioxidant, an α-Glucosidase Inhibitor or a Nrf2-Inducer (2016) · cites this paper as Strong et al., 2008
The cited source says what the claim attributes to it.
In the citing paper
“the failure of NDGA, at 2500 ppm, to increase longevity in female mice (Strong et al., 2008) seems not to be due merely to lower blood concentrations of this agent in females, because we fail to see increased female lifespan even at a concentration, 5000 ppm, that produces blood levels similar to those seen in males at 2500 ppm (Harrison et al., 2014).”
From Longer Lifespan in Male Mice Treated With a Weakly Estrogenic Agonist, an Antioxidant, an α-Glucosidase Inhibitor or a Nrf2-Inducer (2016) · cites this paper as Strong et al., 2008
The cited source says what the claim attributes to it.
In the citing paper
“In the earlier study, 9% of male control mice were alive at the joint 90th percentile age, compared with 13% of NDGA‐treated males (P = 0.12).”
From Longer Lifespan in Male Mice Treated With a Weakly Estrogenic Agonist, an Antioxidant, an α-Glucosidase Inhibitor or a Nrf2-Inducer (2016) · cites this paper as Strong et al., 2008
In the citing paper
“aspirin has been confirmed to extend the lifespan of Drosophila melanogaster and mice in a sex-dependent manner.478,479”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [479]
In the citing paper
“Aspirin improves lifespan in mice”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [273]
In the citing paper
“and oxylipin synthesis inhibitors extend male mouse life span (Strong et al., 2008).”
From Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis (2021) · cites this paper as Strong et al., 2008
In the citing paper
“we tested the effects of NDGA on survival of male and female UM‐HET3 mice at a dose of 2500 ppm and reported that median lifespan was increased in males by 12%, with no benefit in female mice (Strong et al., 2008).”
From Longer Lifespan in Male Mice Treated With a Weakly Estrogenic Agonist, an Antioxidant, an α-Glucosidase Inhibitor or a Nrf2-Inducer (2016) · cites this paper as Strong et al., 2008
In the citing paper
“First, the failure of NDGA, at 2500 ppm, to increase longevity in female mice (Strong et al., 2008) seems not to be due merely to lower blood concentrations of this agent in females”
From Longer Lifespan in Male Mice Treated With a Weakly Estrogenic Agonist, an Antioxidant, an α-Glucosidase Inhibitor or a Nrf2-Inducer (2016) · cites this paper as Strong et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Role of oxygen free radicals in carcinogenesis and brain ischemia
Floyd, R. A. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.9.2189775 · Cited by 877
Self-citationFlurkey, K., Papaconstantinou, J., Miller, R. A., & Harrison, D. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111158898 · Cited by 826
Self-citationIn Search of Methuselah: Estimating the Upper Limits to Human Longevity
Olshansky, S. J., Carnes, B. A., & Cassel, C. (1990) · Science · doi:10.1126/science.2237414 · Cited by 645
Fungal laccase: properties and activity on lignin
Leonowicz, A., Cho, N.-S., Luterek, J., Jarosz‐Wilkołazka, A., Wojtaś-Wasilewska, M., Matuszewska, A., Hofrichter, M., Wesenberg, D., & Rogalski, J. (2001) · Journal of Basic Microbiology · doi:10.1002/1521-4028(200107)41:3/4 · Cited by 578
Handbook of the Biology of Aging
(1986) · Journal of Gerontology · doi:10.1093/geronj/41.1.120 · Cited by 563
Lim, S. S., Gaziano, T. A., Gakidou, E. E., Reddy, K. S., Farzadfar, F., Lozano, R., & Rodgers, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61699-7 · Cited by 373
The mouse as a model for human biology: a resource guide for complex trait analysis
Peters, L. L., Robledo, R. F., Bult, C. J., Churchill, G. A., Paigen, B. J., & Svenson, K. L. (2006) · Nature Reviews Genetics · doi:10.1038/nrg2025 · Cited by 293
Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men
Chan, A. T., Giovannucci, E. L., Meyerhardt, J. A., Schernhammer, E. S., Wu, K., & Fuchs, C. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.035 · Cited by 241
Research works printed but not linked: 2
- 10.1096/fasebj.14.10.1464 · DOI
- Schneider EL, 1998, Brockelhurst's Textbook of Geriatric Medicine, 193
Cited by
Sorted by citations
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Self-citationInflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Spermidine in health and disease
Madeo, F., Eisenberg, T., Pietrocola, F., & Kroemer, G. (2018) · Science · doi:10.1126/science.aan2788 · Cited by 1,154
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096
Metadata
- Authors
- Strong, R., Miller, R. A., Astle, C. M., Floyd, R. A., Flurkey, K., Hensley, K. L., Javors, M. A., Leeuwenburgh, C., Nelson, J. F., Ongini, E., Nadon, N. L., Warner, H. R., & Harrison, D. E.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- University of Michigan (US)
- Jackson Laboratory (US)
- Oklahoma Medical Research Foundation (US)
- University of Florida (US)
- National Institutes of Health (US)
- University of Minnesota (US)
- Corresponding author
- Strong, Randy
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2008-09-17
- Volume
- 7
- Issue
- 5
- Pages
- 641-650
- ISSN
- 1474-9718 (ISSN-L)
- 1474-9726
- PMC
- PMC2695675
- OpenAlex
- W1965507724
- Cited by
- 349
- References
- 54
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 35 · 2023: 16 · 2022: 21 · 2021: 27 · 2020: 21 · 2019: 23 · 2018: 21 · 2017: 24 · 2016: 24 · 2015: 24 · 2014: 14 · 2013: 14 · 2012: 20
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Aging Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institute on Aging (AG 022308, AG13319, P30AG025707, AG022307, AG022303, AG025707, P30AG013319, U01AG022307, P30AG028740, U01AG022308, U01AG022303)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Antioxidants, Aging, Portulaca oleracea
- Keywords
- nordihydroguaiaretic acid, aspirin, lifespan extension, maximum lifespan, genetically heterogeneous mice, age-related diseases, drug metabolism, anti-aging interventions
- MeSH terms
- Animals, Aspirin, Cyclic N-Oxides, Female, Flurbiprofen, Longevity, Male, Mice, Inbred BALB C, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Inbred DBA, Masoprocol, Random Allocation, Sex Characteristics, Survival Analysis, Free Radical Scavengers, Lipoxygenase Inhibitors, Cyclooxygenase Inhibitors, Genetic Heterogeneity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
